← brief for 2026-09-17 · Slowing decline
0077Aromatase Inhibitors Versus Tamoxifen and Cardiovascular-Kidney-Metabolic Stage Progression in Women with Breast Cancer: A Real-World Database Propensity-Matched Cohort Study
Key takeaways
This study compared two breast cancer drugs in women. It looked at how they affect heart and kidney health over five years. It is an observational study, so it shows a link, not proof of cause. It helps doctors choose the safer option for heart and kidney health.
Who did this work
Khalid Alswayed (University of Maryland, Baltimore) · Avinash Saraiya (University of Maryland, Baltimore) · Mostafa Abdelhalim (University of Maryland, Baltimore) · Manu Mysore (University of Maryland, Baltimore)
Source
Article · OpenAlex, CKD works · 2026-09-17
https://doi.org/10.1016/j.ahj.2026.107572